Previous 10 | Next 10 |
home / stock / cphrf / cphrf news
Cipher Pharmaceuticals Announces Management Change & Preliminary Q2 Financial Highlights Cipher Pharmaceuticals Announces Management Change & Preliminary Q2 Financial Highlights Canada NewsWire MISSISSAUGA, ON, July 29, 2019 Company also forms Special Committee ...
Cipher Pharmaceuticals Inc. (CPHRF) Q1 2019 Earnings Conference Call May 10, 2019 8:30 AM ET Company Participants Robert Tessarolo - President and Chief Executive Officer Nadine Jutlah - Interim Chief Financial Officer Conference Call Participants Robert Gibson - PI Financial...
Cipher Pharmaceuticals ( OTC:CPHRF ): Q1 GAAP EPS of $0.03 in-line. More news on: Cipher Pharmaceuticals Inc., Earnings news and commentary, , Read more ...
Cipher Pharmaceuticals Reports First Quarter 2019 Financial Results Canada NewsWire OAKVILLE, ON, May 10, 2019 Revenue increased by 12% to $5.1 million OAKVILLE, ON , May 10, 2019 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today...
Notice of Cipher Pharmaceuticals Q1 2019 Conference Call Canada NewsWire OAKVILLE, ON, May 1, 2019 OAKVILLE, ON , May 1, 2019 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced the details of its Q1 2019 financial results conference ...
Cipher Pharmaceuticals Appoints Mr. Craig Mull to the Board of Directors Canada NewsWire OAKVILLE, ON, March 26, 2019 OAKVILLE, ON , March 26, 2019 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced that Mr. Craig Mull was appointe...
Cipher Pharmaceuticals Announces Change to Management Team Canada NewsWire OAKVILLE, ON, March 20, 2019 OAKVILLE, ON , March 20, 2019 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced that Stephen Lemieux , Chief Financial Officer ...
Cipher Pharmaceuticals Inc. (CPHRF) Q4 2018 Earnings Conference Call March 19, 2019 8:30 A.M. ET Company Participants Robert Tessarolo - President and Chief Executive Officer Stephen Lemieux - Chief Financial Officer and Secretary Conference Call Participants Prasath Panduran...
Cipher Pharmaceuticals ( OTC:CPHRF ): Q4 GAAP EPS of -$0.02. More news on: Cipher Pharmaceuticals Inc., Earnings news and commentary, , Read more ...
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results Canada NewsWire OAKVILLE, ON, March 19, 2019 Canadian product revenue increased 30% to $6.9 million for the year Completed six (6) strategic business transactions enhancing long-term ...
News, Short Squeeze, Breakout and More Instantly...
Companhia Siderurgica Paulista Nova Cosipa Company Name:
CPHRF Stock Symbol:
OTCMKTS Market:
Companhia Siderurgica Paulista Nova Cosipa Website:
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders Canada NewsWire MISSISSAUGA, ON , June 14, 2024 /CNW/ - Cipher Pharmaceuticals Inc . (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the "Company ") today announced that i...
Cipher Pharmaceuticals Reports First Quarter 2024 Results Canada NewsWire (All figures are presented in U.S. Dollars) Adjusted EBITDA in Q1 2024 was $3.6 million , an increase of 12.5% over Q1 2023 Epuris sales volumes grew 7.2% in the quarter over Q1 2023, c...
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , May 3, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release ...